EVALUATION OF BLOOD AND IMMUNE MARKERS IN PATIENTS WITH THROMBOCYTOPENIA
- College of Medicine, University of Thi-Qar, Iraq.
- Ministry of Education, General Directorate for Education in Al- Najaf, Iraq.
- Physiology Department, Hammurabi College of Medicine, Babylon University, Iraq.
- Faculty of Nursing, University of Kufa, Iraq.
- Abstract
- Keywords
- How to Cite This Article
- Corresponding Author
Background:Thrombocytopenia have become a common hematological disorder defined by the reduction of platelet count and is often accompanied by immune dysregulation. This study hasbeen conducted to investigate blood markers (RBC count, hemoglobin, packed cell volume, mean corpuscular hemoglobin) and immune markers (interleukin-6, tumor necrosis factor-alpha, interleukin-10) in patients with thrombocytopenia. Methods: A hospital-based case-control study in Al-Husseuni Hospital and Kerbala City, Iraq between June 2025 and December 2025. The study included a total of 120 subjects, including 58 patients with thrombocytopenia and 62 healthy controls. Blood markers were measured using an automated hematological analyzer, and serum cytokines were quantified by ELISA.
Rand Ali Zeyad et,al (2025); EVALUATION OF BLOOD AND IMMUNE MARKERS IN PATIENTS WITH THROMBOCYTOPENIA, Jana Nexus: Journal of Health and Medicine, 1 (09), 37-45, ISSN (O) 3107-7889. DOI URL: https://dx.doi.org/10.21474/JNHM01/129
College of Medicine, University of Thi-Qar, Iraq.
Iraq
